Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Biochem. 2014 Dec 23;48(0):292–296. doi: 10.1016/j.clinbiochem.2014.12.012

Table 6.

Odds Ratio for the Endpoint of HF Hospitalization or Death, including Galectin 3 and ST2

Unadjusted Logistical Regression Adjusted Logistical Regression *
Biomarker OR (95% CI) P value OR (95% CI) P value
NTproBNP 4.3 (1.6,11.4) 0.0033 1.1 (0.2,5.1) 0.90
IL-6 2.9 (1.3,6.4) 0.0277 1.1 (0.2,5.3) 0.86
TNFα 2.6 (1.2,5.5) 0.0108 0.9 (0.3,2.7) 0.85
cTnI 3.9 (1.8,8.7) 0.0008 2.0 (0.7,5.6) 0.17
VEGF 2.9(1.3,6.4) 0.0073 1.7 (0.6,4.6) 0.28
Sgx-ET1 4.7(2.1,10.5) 0.0002 2.9 (1.1,7.8) 0.03
CT-ET1 9.0(3.7,21.7) <.0001 4.2 (1.2,14.2) 0.02
galectin3 4.0(1.7,9.0) 0.0010 1.9(0.7,5.4) 0.24
ST2 3.0(1.3,7.1) 0.0106 0.7(0.2,2.3) 0.58
*

Adjusted for biomarkers, age, and sex